Method and Apparatus for Determining Cardiac Performance in a Patient with a Conductance Catheter

Abstract

An apparatus for determining cardiac performance in the patient involving a conductance catheter ( 12 ) for measuring conductance and blood volume in a heart chamber of the patient. The apparatus includes a processor ( 14 ) for determining instantaneous volume of the ventricle by applying a non-linear relationship between the measured conductance and the volume of blood in the heart chamber to identify mechanical strength of the chamber. The processor ( 14 ) is in communication with the conductance catheter ( 12 ).

Claims

1 . An apparatus for determining cardiac performance in the patient comprising: a conductance catheter for measuring conductance and blood volume in a heart chamber of the patient; and a processor for determining instantaneous volume of the ventricle by applying a non-linear relationship between the measured conductance and the volume of blood in the heart chamber to identify mechanical strength of the chamber, the processor in communication with the conductance catheter. 2 . An apparatus as described in claim 1 including a pressure sensor for measuring instantaneous pressure of the heart chamber in communication with the processor. 3 . An apparatus as described in claim 2 wherein the processor produces a plurality of desired wave forms at desired frequencies for the conductance catheter. 4 . An apparatus as described in claim 3 wherein the processor produces the plurality of desired wave forms at desired frequencies simultaneously, and the processor separates the plurality of desired wave forms at desired frequencies the processor receives from the conductance catheter. 5 . An apparatus as described in claim 4 wherein the conductance catheter includes a plurality of electrodes to measure a least one segmental volume of the heart chamber. 6 . An apparatus as described in claim 5 wherein the non-linear relationship depends on a number of the electrodes, dimensions and spacing of the electrodes, and an electrical conductivity of a medium in which the electrodes of the catheter are disposed. 7 . An apparatus as described in claim 6 wherein the non-linear relationship is β( G )(σ=0.928 S/m)=1+1.774(10 7.481×10 −4 (G−2057) ) where: G is the measured conductance (S), the calculations have been corrected to the conductivity of whole blood at body temperature (0.928 S/m), and 2057 is the asymptotic conductance in μS when the cuvette is filled with a large volume of whole blood. 8 . An apparatus as described in claim 7 wherein Vol  ( t ) = [ β  ( G ) ] [ L 2 σ b ]  [ Y  ( t ) - Y p ] where: β(G)=the field geometry calibration function (dimensionless), Y(t)=the measured combined admittance, σ b is blood conductivity, L is distance between measuring electrodes, and Y p =the parallel leakage admittance, dominated by cardiac muscle. 9 . An apparatus as described in claim 8 wherein the pressure sensor is in contact with the conductance catheter to measure ventricular pressure in the chamber. 10 . An apparatus as described in claim 9 wherein the plurality of electrodes includes intermediate electrodes to measure and instantaneous voltage signal from the heart, and outer electrodes to which a current is applied from the processor. 11 . An apparatus as described in claim 10 wherein the pressure sensor is disposed between the intermediate electrodes and the outer electrodes. 12 . An apparatus as described in claim 11 wherein the processor includes a computer with a signal synthesizer which produces the plurality of desired wave forms at desired frequencies and a data acquisition mechanism for receiving and separating the plurality of desired wave forms at desired frequencies. 13 . An apparatus as described in claim 12 wherein the computer converts conductance into a volume. 14 . An apparatus as described in claim 13 wherein the computer produces a drive signal having a plurality of desired wave forms at desired frequencies to drive the conductance catheter. 15 . An apparatus as described in claim 6 wherein Vol ( t )=ρ L 2 g b ( t )exp[γ·( g b ( t )) 2 ] where Vol(t) is the instantaneous volume, ρ is the blood resistivity, L is the distance between the sensing electrodes, g b (t) is the instantaneous blood conductance, and γ is an empirical calibration factor. 16 . A method for determining cardiac performance in the patient comprising the steps of: measuring conductance and blood volume in a heart chamber of the patient with a conductance catheter; and determining instantaneous volume of the ventricle by applying a non-linear relationship between the measured conductance and the volume of blood in the heart chamber to identify mechanical strength of the chamber with a processor, the processor in communication with the conductance catheter. 17 . A method as described in claim 16 including the step of measuring instantaneous pressure of the heart chamber with a pressure sensor in communication with the processor. 18 . A method as described in claim 17 including the step of producing a plurality of desired wave forms at desired frequencies for the conductance catheter. 19 . A method as described in claim 18 wherein the producing step includes the step of producing the plurality of desired wave forms at desired frequencies simultaneously, and including the step of the processor separating the plurality of desired way forms at desired frequencies the processor received from the conductance catheter. 20 . A method as described in claim 19 wherein the producing step includes the step of producing with the processor the plurality of desired wave forms at desired frequencies simultaneously. 21 . A method as described in claim 20 wherein the determining step includes the step of applying the non-linear relationship according to β( G )(σ=0.928 S/m)=1+1.774(10 7.481×10 −4 (G−2057) ) where: G is the measured conductance (S), the calculations have been corrected to the conductivity of whole blood at body temperature (0.928 S/m), and 2057 is the asymptotic conductance in μS when the cuvette is filled with a large volume of whole blood. 22 . A method as described in claim 21 wherein the determining step includes the step of determining instantaneous volume according to Vol  ( t ) = [ β  ( G ) ] [ L 2 σ b ]  [ Y  ( t ) - Y p ] where: β(G)=the field geometry calibration function (dimensionless), Y(t)=the measured combined admittance, and Y p =the parallel leakage admittance, dominated by cardiac muscle. 23 . A method as described in claim 22 wherein the step of measuring instantaneous pressure includes the step of measuring instantaneous pressure with the pressure sensor in contact with the conductance catheter to measure the ventricular pressure in the chamber. 24 . A method as described in claim 23 wherein the measuring step includes the step of measuring at least one segmental volume of the heart chamber with a plurality of electrodes on the conductance catheter. 25 . A method as described in claim 24 wherein the measuring step includes the steps of applying a current to outer electrodes of the plurality of electrodes from the processor, and measuring an instantaneous voltage signal from the heart with intermediate electrodes of the plurality of electrodes. 26 . A method as described in claim 25 wherein the step of measuring instantaneous pressure includes the step of measuring instantaneous pressure with the pressure sensor disposed between the intermediate electrodes and the outer electrodes. 27 . An apparatus as described in claim 26 wherein the producing with the processor step includes the step of producing with a signal synthesizer of a computer the plurality of desired wave forms at desired frequencies, and the processor separating step includes the step of receiving and separating the plurality of desired wave forms at desired frequencies with a data acquisition mechanism of the computer. 28 . A method as described in claim 27 including the step of converting conductance into a volume with the computer. 29 . A method as described in claim 28 including the step of producing with the computer a drive signal having the plurality of desired wave forms at desired frequencies to drive the conductance catheter. 30 . A method as described in claim 19 wherein the determining step includes the step of determining instantaneous volume according to Vol ( t )=ρ L 2 g b ( t )exp[γ·( g b ( t )) 2 ] where Vol (t) is the instantaneous volume, σ b is the blood resistivity, L is the distance between the sensing electrodes, g b (t) is the instantaneous blood conductance, and γ is an empirical calibration factor. 31 . An apparatus for determining cardiac performance in a patient comprising: a conductance catheter for measuring conductance in a heart chamber of the patient, where the conductance includes contributions from blood and muscle with respect to the heart chamber; and a processor for determining instantaneous volume of the heart chamber by removing the muscle contribution from the conductance, the processor in communication with the conductance catheter. 32 . An apparatus as described in claim 31 including a pressure sensor for measuring instantaneous pressure of the heart chamber in communication with the processor. 33 . An apparatus as described in claim 32 wherein the processor produces a plurality of desired wave forms at desired frequencies for the conductance catheter. 34 . An apparatus as described in claim 33 wherein the processor produces the plurality of desired wave forms at desired frequencies simultaneously, and the processor separates the plurality of desired wave forms at desired frequencies the processor receives from the conductance catheter. 35 . An apparatus as described in claim 34 wherein the processor measures complex admittance with the conductance catheter to identify the muscle contribution. 36 . An apparatus as described in claim 35 wherein the complex admittance is defined as Yp=Gm+jωCm (Y subscript p) where Cm=capacitance component of muscle (F=Farads) (C subscript m) ω=angular frequency (radians/second) (greek “omega”=2 pi f) Gm=conductance of muscle (S=Siemens) (G subscript m). 37 . An apparatus as described in claim 36 wherein the conductance is defined as Y ( t )= Gb+Gm+jωCm where Gb=conductance of blood (S) (G subscript b). 38 . A method for determining cardiac performance in a patient comprising: measuring conductance in a heart chamber of the patient with a conductance catheter, where the conductance includes contributions from blood and muscle with respect to the heart chamber; and determining instantaneous volume of the heart chamber by removing the muscle contribution from the conductance with a processor, the processor in communication with the conductance catheter. 39 . A method as described in claim 38 including the step of measuring instantaneous pressure of the heart chamber with a pressure sensor in communication with the processor. 40 . A method as described in claim 39 including the step of producing a plurality of desired wave forms at desired frequencies for the conductance catheter. 41 . A method as described in claim 40 wherein the producing step includes the step of producing the plurality of desired wave forms at desired frequencies simultaneously, and including the step of the processor separating the plurality of desired wave forms at desired frequencies the processor received from the conductance catheter. 42 . A method as described in claim 41 wherein the producing step includes the step of producing with the processor the plurality of desired wave forms at desired frequencies simultaneously. 43 . A method as described in claim 42 including the step of measuring complex admittance with the conductance catheter to identify the muscle contribution. 44 . A method as described in claim 43 wherein the measuring the complex admittance step includes the step of measuring the complex admittance according to Yp=Gm+jωCm (Y subscript p) where Cm=capacitance component of muscle (F Farads) (C subscript m) ω=angular frequency (radians/second) (greek “omega”=2 pi f) Gm=conductance of muscle (S=Siemens) (G subscript m). 45 . A method as described in claim 44 wherein the determining step includes the step of determining instantaneous volume based on conductance defined as Y ( t )= Gb+Gm+jωCm where Gb=conductance of blood (S) (G subscript b). 46 . An apparatus for determining cardiac performance in the patient comprising: a conductance catheter for measuring conductance in a heart chamber of the patient; and a processor for determining instantaneous volume of the heart chamber according to Vol  ( t ) = [ β  ( G ) ] [ L 2 σ b ]  [ Y  ( t ) - Y p ] where: β(G)=the field geometry calibration function (dimensionless), Y(t)=the measured combined admittance, and Y p =the parallel leakage admittance, dominated by cardiac muscle, the processor in communication with the conductance catheter. 47 . A method for determining cardiac performance in the patient comprising the steps of: measuring conductance and blood volume in a heart chamber of the patient with a conductance catheter; and determining instantaneous volume of the ventricle according to Vol  ( t ) = [ β  ( G ) ] [ L 2 σ b ]  [ Y  ( t ) - Y p ] where: β(G)=the field geometry calibration function (dimensionless), Y(t)=the measured combined admittance, and Y p =the parallel leakage admittance, dominated by cardiac muscle, to identify mechanical strength of the chamber with a processor, the processor in communication with the conductance catheter.
[0001] This invention was made with government support under National Institute of Health (NIH) Grant No. STTR (HL 67475-01). The government may have certain rights in the invention. FIELD OF THE INVENTION [0002] The present invention is related to measuring instantaneous ventricular volume in the heart of a patient. More specifically, the present invention is related to measuring instantaneous ventricular volume in the heart of a patient by removing the contributor to conductance of muscle, and applying a non-linear relationship to the measured conductance and the volume of blood in the heart. BACKGROUND OF THE INVENTION [0003] Measurements of electrical conductance using a tetrapolar admittance catheter are used to estimate instantaneous ventricular volume in animals and humans. The measurements of volume are plotted against ventricular pressure to determine several important parameters of cardiac physiologic function. A significant source of uncertainty in the measurement is parallel conductance due to current in the ventricular muscle. The estimated volume is larger than the blood volume alone, which is required for the diagnostic measurement. Furthermore, presently, a linear relationship between conductance and estimated volume is used to calibrate the measurements. The actual relationship is substantially nonlinear. [0004] The invention comprises an improved method for estimating instantaneous blood volume in a ventricle by subtracting the muscle contribution form the total conductance measured. The method relies on measuring the complex admittance, rather than apparent conductance (admittance magnitude), as is presently done. Briefly, the improvement consists of measuring the phase angle in addition to admittance magnitude and then directly subtracting the muscle component from the combined measurement, thereby improving the estimate of instantaneous blood volume. The technique works because the electrical properties of muscle are frequency-dependent, while those of blood are not. We propose this calibration technique as a substantial improvement in clinical and research instrumentation calibration methods. [0005] The invention comprises an improved method for estimating instantaneous volume of a ventricle by applying a nonlinear relationship between the measured conductance and the volume of blood in the surrounding space. The nonlinear calibration relation has been determined from experiments and numerical model studies. This calibration technique is a substantial improvement in clinical and research instrumentation calibration methods. SUMMARY OF THE INVENTION [0006] The present invention pertains to an apparatus for determining cardiac performance in the patient. The apparatus comprises a conductance catheter for measuring conductance and blood volume in a heart chamber of the patient. The apparatus comprises a processor for determining instantaneous volume of the ventricle by applying a non-linear relationship between the measured conductance and the volume of blood in the heart chamber to identify mechanical strength of the chamber. The processor is in communication with the conductance catheter. [0007] The present invention pertains to a method for determining cardiac performance in the patient. The method comprises the steps of measuring conductance and blood volume in a heart chamber of the patient with a conductance catheter. There is the step of determining instantaneous volume of the ventricle by applying a non-linear relationship between the measured conductance and the volume of blood in the heart chamber to identify mechanical strength of the chamber with a processor. The processor in communication with the conductance catheter. [0008] The present invention pertains to an apparatus for determining cardiac performance in a patient. The apparatus comprises a conductance catheter for measuring conductance in a heart chamber of the patient, where the conductance includes contributions from blood and muscle with respect to the heart chamber. The apparatus comprises a processor for determining instantaneous volume of the heart chamber by removing the muscle contribution from the conductance. The processor is in communication with the conductance catheter. [0009] The present invention pertains to a method for determining cardiac performance in a patient. The method comprises the steps of measuring conductance in a heart chamber of the patient with a conductance catheter, where the conductance includes contributions from blood and muscle with respect to the heart chamber. There is the step of determining instantaneous volume of the heart chamber by removing the muscle contribution from the conductance with a processor, the processor in communication with the conductance catheter. [0010] The present invention pertains to an apparatus for determining cardiac performance in the patient. The apparatus comprises a conductance catheter having measuring electrodes for measuring conductance in a heart chamber of the patient. The apparatus comprises a processor for determining instantaneous volume of the heart chamber according to [0000] Vol  ( t ) = [ β  ( G ) ]  [ L 2 σ b ]  [ Y  ( t ) - Y p ] [0000] where: β(G)=the field geometry calibration function (dimensionless), Y(t)=the measured combined admittance, σ b is blood conductivity, L is distance between measuring electrodes, and Y p =the parallel leakage admittance, dominated by cardiac muscle, the processor in communication with the conductance catheter. [0011] The present invention pertains to a method for determining cardiac performance in the patient. The method comprises the steps of measuring conductance and blood volume in a heart chamber of the patient with a conductance catheter having measuring electrodes. There is the step of determining instantaneous volume of the ventricle according to [0000] Vol  ( t ) = [ β  ( G ) ]  [ L 2 σ b ]  [ Y  ( t ) - Y p ] [0000] where: β(G)=the field geometry calibration function (dimensionless), Y(t)=the measured combined admittance, σ b is blood conductivity, L is distance between measuring electrodes, and Y p =the parallel leakage admittance, dominated by cardiac muscle, to identify mechanical strength of the chamber with a processor. The processor is in communication with the conductance catheter. BRIEF DESCRIPTION OF THE DRAWINGS [0012] In the accompanying drawings, the preferred embodiment of the invention and preferred methods of practicing the invention are illustrated in which: [0013] FIG. 1 shows a four electrode catheter in volume cuvette. [0014] FIG. 2 is a plot for estimating parallel conductance. [0015] FIG. 3 is a plot of apparent conductivity of cardiac muscle as a function of frequency in CD1 mice in vivo at 37° C. [0016] FIG. 4 shows a circuit diagram of a catheter and a measurement system for an open circuit load. The small triangles are the common node for the instrument power supply. [0017] FIG. 5 is a plot of catheter phase effects for saline solutions from 720 to 10,000 μS/cm from 1 kHz to 1 MHz. Apparent conductivity (|η|) of saline solutions (μS/cm). [0018] FIG. 6 is a plot of conductance vs. volume in mouse-sized calibration cuvette. [0019] FIG. 7 is a schematic representation of the apparatus of the present invention. [0020] FIG. 8 is a cylinder-shaped murine LV model: both blood and myocardium are modeled as cylinders. [0021] FIG. 9 is a comparison between true volume and estimated volume by the new and Baan's equations in FEMLAB simulations. [0022] FIG. 10 is a comparison between true volume and estimated volume using the new and Baan's equations in saline experiments. DETAILED DESCRIPTION [0023] Referring now to the drawings wherein like reference numerals refer to similar or identical parts throughout the several views, and more specifically to FIG. 7 thereof, there is shown an apparatus for determining cardiac performance in the patient. The apparatus comprises a conductance catheter 12 for measuring conductance and blood volume in a heart chamber of the patient. The apparatus comprises a processor 14 for determining instantaneous volume of the ventricle by applying a non-linear relationship between the measured conductance and the volume of blood in the heart chamber to identify mechanical strength of the chamber. The processor 14 is in communication with the conductance catheter 12 . [0024] Preferably, the apparatus includes a pressure sensor 16 for measuring instantaneous pressure of the heart chamber in communication with the processor 14 . The processor 14 preferably produces a plurality of desired wave forms at desired frequencies for the conductance catheter 12 . Preferably, the processor 14 produces the plurality of desired wave forms at desired frequencies simultaneously, and the processor 14 separates the plurality of desired wave forms at desired frequencies the processor 14 receives from the conductance catheter 12 . The conductance catheter 12 preferably includes a plurality of electrodes 18 to measure a least one segmental volume of the heart chamber. [0025] Preferably, the non-linear relationship depends on a number of the electrodes 18 , dimensions and spacing of the electrodes 18 , and an electrical conductivity of a medium in which the electrodes 18 of the catheter 12 are disposed. The non-linear relationship may be expressed as (or a substantially similar mathematical form): [0000] β( G )(σ=0.928 S/m)=1+1.774(10 7.481×10 −4 (G−2057) ) [0026] Alternatively, an approximate calibration factor may be used with similar accuracy of the form (or its mathematical equivalent): [0000] β≅e γG h 2 [0000] where: G is the measured conductance (S), the calculations have been corrected to the conductivity of whole blood at body temperature (0.928 S/m), and 2057 is the asymptotic conductance in μS when the cuvette is filled with a large volume of whole blood. Preferably, [0000] Vol  ( t ) = [ β  ( G ) ]  [ L 2 σ b ]  [ Y  ( t ) - Y p ] [0000] where: β(G)=the field geometry calibration function (dimensionless), Y(t)=the measured combined admittance, σ b is blood conductivity, L is distance between measuring electrodes, and Y p =the parallel leakage admittance, dominated by cardiac muscle. [0027] The pressure sensor 16 preferably is in contact with the conductance catheter 12 to measure ventricular pressure in the chamber. Preferably, the plurality of electrodes 18 includes intermediate electrodes 20 to measure the instantaneous voltage signal from the heart, and outer electrodes 22 to which a current is applied from the processor 14 . The pressure sensor 16 preferably is disposed between the intermediate electrodes 20 . Preferably, the processor 14 includes a computer 24 with a signal synthesizer 26 which produces the plurality of desired wave forms at desired frequencies and a data acquisition mechanism 28 for receiving and separating the plurality of desired wave forms at desired frequencies. The computer 24 preferably converts conductance into a volume. Preferably, the computer 24 produces a drive signal having a plurality of desired wave forms at desired frequencies to drive the conductance catheter 12 . [0028] The present invention pertains to a method for determining cardiac performance in the patient. The method comprises the steps of measuring conductance and blood volume in a heart chamber of the patient with a conductance catheter 12 . There is the step of determining instantaneous volume of the ventricle by applying a non-linear relationship between the measured conductance and the volume of blood in the heart chamber to identify mechanical strength of the chamber with a processor 14 . The processor 14 in communication with the conductance catheter 12 . [0029] Preferably, there is the step of measuring instantaneous pressure of the heart chamber with a pressure sensor 16 in communication with the processor 14 . There is preferably the step of producing a plurality of desired wave forms at desired frequencies for the conductance catheter 12 . Preferably, the producing step includes the step of producing the plurality of desired wave forms at desired frequencies simultaneously, and including the step of the processor 14 separating the plurality of desired wave forms at desired frequencies the processor 14 received from the conductance catheter 12 . The producing step preferably includes the step of producing with the processor 14 the plurality of desired wave forms at desired frequencies simultaneously. [0030] Preferably, the determining step includes the step of applying the non-linear relationship according to the following (or its mathematical equivalent): [0000] β( G )(σ=0.928 S/m)=1+1.774(10 7.481×10 −4 (G−2057) ) [0000] where: G is the measured conductance (S), the calculations have been corrected to the conductivity of whole blood at body temperature (0.928 S/m), and 2057 is the asymptotic conductance in μS when the cuvette is filled with a large volume of whole blood. Or, alternatively, an approximate geometry calibration factor may be used: [0000] β=e γ[G b ] 2 [0000] where α is determined experimentally or from mathematical calculations or numerical models. [0031] The determining step preferably includes the step of determining instantaneous volume according to [0000] Vol  ( t ) = [ β  ( G ) ] [ L 2 σ b ]  [ Y  ( t ) - Y p ] [0000] where: β(G)=the field geometry calibration function (dimensionless), Y(t)=the measured combined admittance, σ b is blood conductivity, L is distance between measuring electrodes, and Y p =the parallel leakage admittance, dominated by cardiac muscle. [0032] Preferably, the step of measuring instantaneous pressure includes the step of measuring instantaneous pressure with the pressure sensor 16 in contact with the conductance catheter 12 to measure the ventricular pressure in the chamber. The measuring step preferably includes the step of measuring at least one segmental volume of the heart chamber with a plurality of electrodes 18 on the conductance catheter 12 . Preferably, the measuring step includes the steps of applying a current to outer electrodes 22 of the plurality of electrodes 18 from the processor 14 , and measuring an instantaneous voltage signal from the heart with intermediate electrodes 20 of the plurality of electrodes 18 . [0033] The step of measuring instantaneous pressure preferably includes the step of measuring instantaneous pressure with the pressure sensor 16 disposed between the intermediate electrodes 20 and the outer electrodes 22 . Preferably, the producing with the processor 14 step includes the step of producing with a signal synthesizer 26 of a computer 24 the plurality of desired wave forms at desired frequencies, and the processor 14 separating step includes the step of receiving and separating the plurality of desired wave forms at desired frequencies with a data acquisition mechanism 28 of the computer 24 . There is preferably the step of converting conductance into a volume with the computer 24 . Preferably, there is the step of producing with the computer 24 a drive signal having the plurality of desired wave forms at desired frequencies to drive the conductance catheter 12 . [0034] The present invention pertains to an apparatus for determining cardiac performance in a patient. The apparatus comprises a conductance catheter 12 for measuring conductance in a heart chamber of the patient, where the conductance includes contributions from blood and muscle with respect to the heart chamber. The apparatus comprises a processor 14 for determining instantaneous volume of the heart chamber by removing the muscle contribution from the conductance. The processor 14 is in communication with the conductance catheter 12 . [0035] Preferably, the apparatus includes a pressure sensor 16 for measuring instantaneous pressure of the heart chamber in communication with the processor 14 . The processor 14 preferably produces a plurality of desired wave forms at desired frequencies for the conductance catheter 12 . Preferably, the processor 14 produces the plurality of desired wave forms at desired frequencies simultaneously, and the processor 14 separates the plurality of desired wave forms at desired frequencies the processor 14 receives from the conductance catheter 12 . The processor 14 preferably measures complex admittance with the conductance catheter 12 to identify the muscle contribution. [0036] Preferably, the complex admittance is defined as [0000] Y p =Gm+jωCm (Y subscript p) [0000] where [0037] Cm=capacitance component of muscle (F=Farads) (C subscript m) [0038] ω=angular frequency (radians/second) (greek “omega”=2 p f) [0039] Gm=conductance of muscle (S=Siemens) (G subscript m). The conductance preferably is defined as [0000] Y ( t )= Gb+Gm+jωCm [0000] where Gb=conductance of blood (S) (G subscript b). [0040] The present invention pertains to a method for determining cardiac performance in a patient. The method comprises the steps of measuring conductance in a heart chamber of the patient with a conductance catheter 12 , where the conductance includes contributions from blood and muscle with respect to the heart chamber. There is the step of determining instantaneous volume of the heart chamber by removing the muscle contribution from the conductance with a processor 14 , the processor 14 in communication with the conductance catheter 12 . [0041] Preferably, there is the step of measuring instantaneous pressure of the heart chamber with a pressure sensor 16 in communication with the processor 14 . There is preferably the step of producing a plurality of desired wave forms at desired frequencies for the conductance catheter 12 . Preferably, the producing step includes the step of producing the plurality of desired wave forms at desired frequencies simultaneously, and including the step of the processor 14 separating the plurality of desired wave forms at desired frequencies the processor 14 received from the conductance catheter 12 . The producing step preferably includes the step of producing with the processor 14 the plurality of desired wave forms at desired frequencies simultaneously. Preferably, there is the step of measuring complex admittance with the conductance catheter 12 to identify the muscle contribution. [0042] The measuring the complex admittance step preferably includes the step of measuring the complex admittance according to [0000] Yp=Gm+jωCm (Y subscript p) [0000] where [0043] Cm=capacitance component of muscle (F=Farads) (C subscript m) [0044] ω=angular frequency (radians/second) (greek “omega”=2 pi f) [0045] Gm=conductance of muscle (S=Siemens) (G subscript m). [0046] Preferably, the determining step includes the step of determining instantaneous volume based on conductance defined as [0000] Y ( t )= Gb+Gm+jωCm [0000] where Gb=conductance of blood (S) (G subscript b). [0047] The present invention pertains to an apparatus for determining cardiac performance in the patient. The apparatus comprises a conductance catheter 12 for measuring conductance in a heart chamber of the patient. The apparatus comprises a processor 14 for determining instantaneous volume of the heart chamber according to [0000] Vol  ( t ) = [ β  ( G ) ] [ L 2 σ b ]  [ Y  ( t ) - Y p ] [0000] where: β(G)=the field geometry calibration function (dimensionless), Y(t)=the measured combined admittance, σ b is blood conductivity, L is distance between measuring electrodes, and Y p =the parallel leakage admittance, dominated by cardiac muscle, the processor 14 in communication with the conductance catheter 12 . [0048] The present invention pertains to a method for determining cardiac performance in the patient. The method comprises the steps of measuring conductance and blood volume in a heart chamber of the patient with a conductance catheter 12 . There is the step of determining instantaneous volume of the ventricle according to [0000] Vol  ( t ) = [ β  ( G ) ] [ L 2 σ b ]  [ Y  ( t ) - Y p ] [0000] where: β(G)=the field geometry calibration function (dimensionless), Y(t)=the measured combined admittance, σ b is blood conductivity, L is distance between measuring electrodes, and Y p =the parallel leakage admittance, dominated by cardiac muscle, to identify mechanical strength of the chamber with a processor 14 . The processor 14 is in communication with the conductance catheter 12 . [0049] The classic means to determine left ventricular pressure-volume (PV) relationships in patients on a beat-by-beat basis is through the use of the conductance (volume) catheter 12 . The electric field that it creates in the human left ventricle at the time of heart catheterization is the only technology capable of measuring instantaneous left ventricular volume during maneuvers such as transient occlusion of the inferior vena cava. Such maneuvers allow determination of the wealth of information available from the PV plane including: end-systolic elastance, diastolic compliance, and effective arterial elastance. However, use of conductance technology in patients with dilated hearts whose LV volumes can range from 200 to 500 ml has been problematic. [0050] The G-V method measures the conductance between electrodes 18 located in the LV and aorta. A minimum of four electrodes 18 is required to prevent the series impedance of the electrode-electrolyte interfaces from distorting the measurement. Typically, the two current source-sink electrodes are located in the aorta and in the LV near the apex (electrodes 1 and 4 in FIG. 1 ). The potential difference between the potential measuring electrodes ( 2 and 3 ) is used to calculate the conductance: G=I/V. The governing assumption is that the current density field is sufficiently uniform that the volume and conductance are simply related by Baan's equation [1]: [0000] Vol  ( t ) = [ 1 α ] [ L 2 σ b ]  [ G  ( t ) - G p ] ( 1 ) [0000] where: α is the geometry factor (a dimensionless constant), L is the center-to-center distance between voltage sensing electrodes ( 2 and 3 ) (m), σ b is the conductivity of blood (S/m), G(t) is the measured instantaneous conductance (S), and G p is the parallel conductance (S) in cardiac muscle (G p =0 in the calibration cuvette of FIG. 1 ). [0051] Two limitations inherent in the state-of-the-art technique interfere with accurate measurements: 1) the electric field around the sensing electrodes 18 is not uniform, leading to a non-linear relationship between measured conductance and ventricular volume which has decidedly lower sensitivity to large volumes, and 2) the parallel conductance signal added by surrounding cardiac muscle adds virtual volume to the measurement. The new technique improves the estimate of the parallel muscle conductance based on the measurement of complex admittance at two or more frequencies, rather than using the admittance magnitude, as is presently done. Furthermore, the inherent non-linearity of conductance vs. volume is usually compensated by establishing a piece-wise linear approximation to the sensitivity curve (Vol vs. G) in the region of operation. That is, a is actually a function of the diameter of the volume in FIG. 1 ; but is assumed constant over the operating range of a measurement, ESV to EDV. [0052] The electrical properties of cardiac muscle are frequency-dependent [6-14] while those of blood are not [15-18]. The admittance measurement at (at least) two frequencies can be used to separate the muscle component from the combined muscle-blood signal. Measurement of the phase angle of the admittance is a more sensitive indicator of the muscle signal than the magnitude of the admittance, which is currently measured. Information contained in the phase angle can improve the overall accuracy of the dual frequency admittance system. This reformulation of the measurement allows one to verify that the effective sensing volume actually reaches the ventricular muscle in the case of an enlarged heart. [0053] In the operation of the invention, the parallel conductance signal is presently compensated by three methods: 1) hypertonic saline injection [19, 20], 2) occlusion of the inferior vena cava (IVC) [21], and 3) conductance measurement at two frequencies [22, 23]. In the first approach, a known volume of hypertonic saline (usually 10% NaCl) is injected and the beat-by-beat conductance signal measured as it washes through the LV during several beats. The End Diastolic Conductance (EDG) is plotted against End Systolic Conductance (ESG), and the resulting line is projected back to the line of equal values (EDG=ESG when stroke volume=0), and the remainder is the estimate of parallel conductance, G p . (see FIG. 2 .). In the second approach, occlusion of the IVC, shrinks the LV volume, but the result is analyzed in the same way as FIG. 2 . The third approach attempted to use the frequency dependence of muscle to identify the parallel conductance [22, 23]. This is similar to the approach described here, but different in that the particular frequencies were limited to a maximum of about 30 kHz and only the magnitude of the combined signal was used. A maximum frequency of 100 kHz is used here to better separate the muscle from the combined signal; further, the phase angle is a much more sensitive indicator of muscle than admittance magnitude alone. [0054] Each of the parallel conductance compensation approaches has undesirable features. Hypertonic saline injection creates an aphysiologic electrolyte load that is undesirable in the failing heart. IVC occlusion brings the ventricular free wall and septum closer to the electrode array and artificially inflates the parallel conductance. The dual frequency measurements are able to identify a difference signal between blood and cardiac muscle, but measurement using the magnitude of admittance alone is not sufficiently sensitive to yield satisfying results, and the particular frequencies used in the past are not the best to separate the two signals. There are other considerations in the dual-frequency measurement which affect overall accuracy—notably the parasitic impedances in the catheter 12 itself—which must be compensated before reliable calculations may be made. The present invention is a significant improvement to the dual frequency method; it uses measurements of the complex admittance to more accurately identify the parallel muscle volume signal and does not require injecting fluids or changing the LV volume to complete. [0055] Frequency Dependence of Muscle Electrical Properties: Electrolytic solutions, blood and all semiconducting materials have an electrical conductivity, σ, that is essentially independent of frequency. Dielectric materials have an electric permittivity, ∈ (F/m): in essence, permittivity is a measure of the polarizable dipole moment per unit volume in a material [14]. A general material has both semiconducting and dielectric properties, and each aspect contributes to the total current density vector, J tot (A/m 2 ) in a vector electric field, E (V/m). The conductivity, σ, results in conduction current density according to Ohm's Law, and the permittivity, ∈, contributes “displacement” current density in a harmonic (i.e. sinusoidal) electric field, as reflected in the right hand side of Ampere's Law [40]: [0000] J tot =(σ+ j ω∈) E   (2) [0000] where: j=√{square root over (−1)}, and ω=2πf=the angular frequency (r/s). J tot is complex even if E is real—in other words, J and E are not in phase with each other unless ω∈ is small with respect to σ. Most all tissues behave as semiconductors at all frequencies below about 10 MHz because σ>>ω∈. The remarkable exception is muscle tissue in vivo or very freshly excised, [10-12, and our own unpublished measurements]. To calibrate this discussion, water has a very strong dipole moment, and has a relative permittivity of around 80 at frequencies below about 1 MHz; and the relative permittivities of most tissues are, therefore, usually dominated by their water content. Muscle, in contrast, has a very high relative permittivity: around 16,000 in the 10 kHz to 100 kHz range (almost 200 times that of water) [11], owing to the trans-membrane charge distribution. Consequently, ω∈ are able to observe the frequency dependence of muscle total current density since ω∈ is larger than a for frequencies above about 15 kHz. [0056] For example, the apparent conductivity of murine cardiac muscle using a surface tetrapolar probe shows a reliable and repeatable frequency dependence. In FIG. 3 , the indicated conductivity increases significantly above about 10 kHz. The conductivity in the figure includes some permittivity effects: the measurement device actually indicates the magnitude of the (σ+jω∈) term in equation 2. For muscle, it is more accurate to think in terms of “admittivity”, η=σ+jω∈. σ=1,800 μS/cm (0.18 S/m) from the low frequency portion of the plot, and estimate that ∈=16,000 ∈ 0 (F/m) which compares well with published data. In the figure, the parasitic capacitances of the surface probe have been compensated out using measurements of the surface probe on electrolytic solutions with the same baseline conductivity as muscle. [0057] Numerical Model Studies: Numerical models of the murine catheter in a mouse LV were executed at volumes representative of the normal ESV and EDV in the mouse. The numerical model was an enhanced version of the model used for the cuvette studies: each control volume (CV) could be assigned a different value of electrical conductivity, σ. The model spatial resolution and FDM calculational approach were the same as described above. A larger number of iterations were required for convergence, however, around 400,000 iterations. This is because the electrical boundary conditions of the inhomogeneous media substantially increase the number of trials required to settle to the final solution. Models were completed using realistic volumes for ESV and EDV derived from conductance catheter 12 data: 19 μl and 45 μl, respectively (ejection fraction 60%). Electrical conductivities for blood, cardiac muscle and aorta were: σ b =0.928 S/m, σ m =0.0945 S/m at 10 kHz and 0.128 S/m at 100 kHz, σ a =0.52 S/m [41], respectively. All of the properties are real-valued in the model—the complex nature of muscle has not been included in the preliminary studies. The ventricular free wall endocardial surface was treated as a smooth ellipse, and the LV was modeled as an ellipsoid of revolution. The geometry was considerably simplified over the actual LV for two reasons: 1) the purpose of the model was to identify the expected order-of-magnitude of muscle contribution to the measured conductance, 2) the resources and time available did not permit development of a detailed 3-D geometry, nor the use of more accurate finite element method (FEM) models. [0058] Table 1 compares FDM model and experiment data. The model consistently under-estimates the measured conductances: by about 11% and 35% at 10 kHz, and by 30% and 47% at 100 kHz. The comparisons at 10 kHz are least sensitive to uncertainty in tissue electrical properties and catheter 12 effects. Deviations at this frequency are more likely due to geometric simplifications in the model and under-estimation of the appropriate LV volume to use. [0000] TABLE 1 Summary of model and experimental conductance values (μS). Experimental data are the means of six normal mice [28], numbers in parentheses are standard deviations. Source EDV ESV FDM Model @ 10 kHz 1419 μS 844 μS Experiment @ 10 kHz 1600 (500) 1300 (400) FDM Model @ 100 kHz 1493 905 Experiment @ 100 kHz 2100 (400) 1700 (400) [0059] The 100 kHz measurements reveal an additional effect due to the complex nature of the electrical properties of muscle and the effect of capacitance between the wires in the conductance catheter 12 . While the actual values of the calculated conductance are subject to many uncertainties, the differences between 10 kHz and 100 kHz values in the model are due only to the electrical properties of muscle. So, in Table 1 it looks at first glance as though the model work has severely underestimated the capacitive effects in muscle. However, it must be noted that the reported in vivo measurements do not compensate out the stray capacitance in the catheter 12 at 100 kHz. At this point, it is not clear precisely how much of the apparent frequency-dependent signal is due to catheter 12 capacitance, and how much is due to muscle signal in those data. [0060] The improved muscle parallel conductance compensation technique described can be implemented in existing conductance machines either in embedded analysis software (real-time or off-line processing of measured data) or in dedicated Digital Signal Processing hardware devices. [0061] Phase Angle Measurement: There is an embedded difficulty in this measurement which must be addressed: the parasitic capacitance of the catheters has effects on the measured admittance signal phase angle in addition to the muscle permittivity component. One necessarily measures the two together; and a method for compensating out or otherwise dealing with the catheter-induced effects is required. Fortunately, all of the necessary catheter 12 characteristics can be measured a priori. We have identified three approaches to this problem. [0062] First, the catheter 12 phase angle effects stem from parasitic capacitance between electrode wires in the catheter 12 . The tetrapolar case is relatively easy to discuss, and the multi-electrode catheters consist of several repeated combinations of the 4-electrode subunit. We can measure the six inter-electrode parasitic capacitances of the 4-electrode systems ( FIG. 4 ). The effect of the inter-electrode capacitances can be reduced to a single capacitive admittance in parallel with the tissues, C cath , much larger than any of the C ij . This can be seen in experimental measurements on saline which has no observable permittivity effects at frequencies below about 200 MHz; thus, all capacitance information (frequency-dependent increase in |η|, where η=σ+jω∈) in the signal comes from catheter 12 effects ( FIG. 5 ). In FIG. 5 a small conductivity measurement probe (inter-electrode capacitances from 60 to 70 pF) has been used to measure the apparent conductivity (|η|) of saline solutions between 720 μS/cm (lowest line) and 10,000 ηS/cm (highest line). The lines cross because the point where σ NaCl =ω∈ cath moves to higher frequency for higher σ. C cath is approximately 1.5 nF here. [0063] Second, a lumped-parameter circuit model can be constructed for catheter 12 effects and use this model to correct the measured potential, ΔV, to the value it would have in the absence of the parasitic capacitances. Third, we can advance the measurement plane from the current-source output, I s , ( FIG. 5 ) and voltage measurement location, ΔV, to the outside surfaces of the four electrodes 18 using a bilinear transform. This is a standard approach in impedance measurement [see ref. 14, Ch. 5] and requires only a measurement at open circuit, short circuit and a normalizing load (say, 1 kΩ) to accomplish. [0064] The first approach is the most practical for implementation in a clinical instrument: we will subtract the catheter 12 capacitance, C cath , (measured a priori) from the total capacitance of the measurement, C tot , with the remainder: C muscle =C tot −C cath . The measurement from 2 to 10 kHz includes only the real parts: Y 10 =G b +G musc . At 100 kHz: Y 100 =G b +G musc +jω(C cath +C musc ). Negative values are rejected and C cath is deterministic and not time-varying. The calculation strategy is then: C tot =|Y 100 | sin(θ tot )/ω; C musc =C tot −C cath ; finally, G p =G musc =σ m C musc /∈ musc (from the well known conductance-capacitance analogy [40]) and G p can be subtracted from |Y 10 | to determine G b —i.e. |Y 10 |=G b +G p . A purely analog approach to this measurement is impossible, and a mixed signal approach with extensive digital processing required for both catheter 12 compensation and phase measurement is used. Based on the model trends and measured values of Table 1, it is estimated the relative phase angles in the measured admittance ought to be approximately 4° for EDV and 8° for ESV. The larger phase angle for ESV reflects the change in relative proximity of the LV wall. [0065] The non uniformity of the electrode sensing field is inherent in the single current source electrode geometry of FIG. 1 . Two limiting cases illustrate the origin of this. First, for a sufficiently large cuvette or blood volume, the electric and current density fields surrounding electrodes 1 and 4 are similar in overall shape to those of a current dipole: the magnitude of the current density decreases with the cube of the radius. At very large volume the voltage measured between electrodes 2 and 3 is insensitive to the location of the outer boundary. Consequently, the measured conductance saturates at large volumes since the sensitivity, ΔG/ΔVol=0, and thus α=zero. Second, the other limit is reached when the outer radius of the volume is minimally larger than the catheter 12 itself. In that case the current density approaches a uniform distribution and α approaches 1. Radii between these limits cross over from α=1 to α=0. [0066] The behavior of α was studied in experiments and numerical models of a mouse-sized 4-electrode conductance catheter 12 in a volume-calibration cuvette. This catheter 12 has L=4.5 mm between the centers of electrodes 2 and 3 and is 1.4 F (i.e. 0.45 mm in diameter). The cuvette was filled with 1 M saline solution (σ=1.52 S/m at room temperature). The results are summarized in FIG. 3 . In the Figure, “Ideal G” is the line α=1. The numerically calculated (squares) and measured (circles) conductance in μS are plotted vs. cuvette volume (μl). The measurement sensitivity, ΔG/ΔVol, in the figure=α(σ/L 2 ), and this slope asymptotically approaches 0 for volumes greater than about 150 μl for this catheter 12 . This behavior is determined solely by the geometry of the current density field, and α is independent of the conductivity of the solution. [0067] Based on the numerical model and experimental results, a new calibration equation using β(G) as the geometry calibration function to replace a in equation 4: [0000] Vol  ( t ) = [ β  ( G ) ] [ L 2 σ b ]  [ Y  ( t ) - Y p ] ( 4 ) [0000] where: β(G)=the field geometry calibration function (dimensionless), Y(t)=the measured combined admittance, σ b is blood conductivity, L is distance between measuring electrodes, and Y p =the parallel “leakage” admittance, dominated by cardiac muscle. At small volumes, β(G)=α=1. At large volumes, β(G) increases without bound, as expected from the model work in FIG. 6 . The new calibration function includes the non-linear nature of the volume calculation: since for a particular catheter β(G) depends on the conductivity of the liquid and on measured G—i.e. on cuvette and/or ventricular blood outer radius—it is not simply expressible in terms of 1/α. The expression for β(G) for the mouse-sized catheter 12 described above for FIG. 6 data is: [0000] β( G )(σ=0.928 S/m)=1+1.774(10 7.481×10 −4 (G−2057) )  (5) [0000] where: G is the measured conductance (S), the calculations have been corrected to the conductivity of whole blood at body temperature (0.928 S/m), and 2057 is the asymptotic conductance in μS when the cuvette is filled with a large volume of whole blood. Here β(G) depends only on the real part of Y because the cuvette measurements do not contain muscle. In use, G is the real part of [Y(t)−Y p ], and any imaginary part of the signal is rejected since it must come from a muscle component, or from the instrumentation. As required, β(G) approaches 1 as G becomes small compared to the asymptote, 2057 μS. [0068] The improved calibration method can be implemented in existing conductance machines either in embedded analysis software (real-time or off-line processing of measured data) or in dedicated Digital Signal Processing hardware devices. [0069] Complex admittance in regard to overall admittance as it relates to Y(t)−Y p is as follows. [0000] Y ( t )= Gb+Gm+jωCm [0000] Y p =Gm+jωCm ( Y p ) [0070] C m =capacitance component of muscle (F=Farads) (C m ) [0071] ω=angular frequency (radians/second) (s=2 π f) [0072] Gm=conductance of muscle (S=Siemens) (G m ) [0073] Gb=conductance of blood (S) (G b ) [0000] Y(t)=total instantaneous measured admittance (S) (after catheter 12 effects have been compensated. Y p =total parallel admittance (everything but blood). The cardiac muscle dominates Y p ; and thus once Y p is known (from the measurement of phase angle—only muscle has capacitance and contributes to the phase angle) the estimate of G b can be improved and thus the volume of blood. [0074] The following elaborates on the nonlinear relationship β(G) between conductance and volume. 1. Physical Principle: [0075] β(G) is a nonlinear function for every admittance (conductance) catheter 12 . The function depends on the number, dimensions and spacing of the electrodes 18 used, and on the electrical conductivity of the medium which it is in. β(G) is determined by the shape of the current field created by the electrodes 18 . 2. Experimental Determination [0076] β(G) may be determined experimentally for any conductance catheter 12 in cylindrical “cuvettes” in which a solution of known electrical conductivity is measured over a range of cuvette diameters. The “volume” is the volume of solution between the voltage sensing electrodes 18 . 3. Determination by Solution of the Electric Field Equations [0077] β(G) may also be determined by solving the governing electric field equations, namely Gauss' Electric Law—either in integral form or in the form of the Laplace at low frequency, and the wave equations at high frequency—subject to appropriate boundary conditions. The solution may be by analytical means (paper and pencil) or by numerical means, as in a digital computer 24 model of the electric and/or electromagnetic fields. For any current field established by two or more electrodes 18 a model yields the measured conductance when the total current—surface integral of (sigma mag(E) dot product dS), where dS is the elemental area—is divided by the measurement electrode voltage, from the model or calculation results. Many books on electromagnetic field theory teach how to make the calculation. A specific reference is Chapter 6 (p. 184) in W. H. Hayt and J. A. Buck “Engineering Electromagnetics”, 6th Edition McGraw-Hill, Boston, 2001, incorporated by reference herein. The specific reference teaches how to calculate resistance, R, but conductance, G is simply the reciprocal of R, G=1/R. The calculated G may be a complex number (for mixed materials like tissues), in which case the catheter 12 measures “admittance”, Y, a complex number. (A) Measured Conductance and Capacitance Signals [0078] Two of the catheter electrodes (# 1 and # 4 ) are used to establish a current field in the ventricle. The current field results in an electric field in the tissues, the strength of which is determined by measuring the voltage between electrodes # 2 and # 3 . Because electrodes 2 and 3 carry negligible amounts of current, they provide a useful estimate of the electric field in the tissues. The current supplied to the tissue (electrodes 1 and 4 ) is divided by the voltage measured between electrodes 2 and 3 to determine the admittance of the tissue, Y (S). The admittance consists of two parts, the Conductance, G (S) the real part, and the Susceptance, B (S), the imaginary part: Y=G+jB. In this measurement, both blood and muscle contribute to the real part of the measured signal, G=G b +G musc . However, after all catheter-induced effects have been removed, only the muscle can contribute to the imaginary part, B=jωC musc . [0079] For any geometry of electric field distribution in a semiconducting medium, the conductance may be calculated from: [0000] G = I V = ∫ ∫ S   σ   E ·  S - ∫ a b  E ·   l ( a ) [0000] where the surface, S, in the numerator is chosen to enclose all of the current from one of the electrodes used to establish the electric field, E, and the integration pathway in the denominator is from the low voltage “sink” electrode at position “a” to the higher voltage “source” electrode at position “b”. Similarly, for any geometry of electric field in a dielectric medium, the capacitance may be calculated from: [0000] C = Q V = ∫ ∫ S   ɛ   E ·  S - ∫ a b  E ·   l ( b ) B) Parallel Admittance in the Cardiac Muscle [0080] The measured tissue signal, Y=G b +G musc +jωC musc . From the high frequency measurement C musc may be determined from the measured phase angle by: C musc =|Y| sin(θ)/ω after catheter phase effects have been removed. By equations (a) and (b) above, the muscle conductance can be determined from its capacitance by: G musc =σ/∈C musc since the two equations differ only by their respective electrical properties—i.e. the electric field geometry calculations are identical in a homogeneous medium. In this way, the muscle conductance (independent of frequency, and thus the same in the low frequency and high frequency measurements) may be determined from the muscle capacitance (observable only in the high frequency measurements). [0081] Beyond these very general relations, a person may make catheter electrode configurations of many shapes and sizes and use them in many sorts of conductive solutions. All would have a different β(G) function. [0082] In an alternative embodiment, the LV volume signal is only relative to LV blood conductance, but the measured admittance comes from both blood and myocardium. Therefore, it is desired to extract the blood conductance from the measured admittance, which can be done by using the unique capacitive property of myocardium. To achieve it, the first step is to obtain the conductivity and permittivity of myocardium. Myocardial Conductivity and Permittivity [0083] It is believed that blood is only conductive, while myocardium is both conductive and capacitive. Therefore, the measured frequency-dependent myocardial “admittivity”, Y′ m (f), actually is composed of two components: [0000] Y′ m ( f )=√{square root over (σ m 2 +(2 πf∈ r ∈ 0 ) 2 )}  (6) [0000] where σ m is the real myocardial conductivity, f is frequency, ∈ r is the relative myocardial permittivity, and ∈ 0 is the permittivity of free space. Experimentally, Y′ m (f) can be measured at two different frequencies, such as 10 and 100 kHz, and then the value of σ m and myocardial permittivity ∈ can be calculated by: [0000] σ m = 100 · [ Y m ′  ( 10   k ) ] 2 - [ Y m ′  ( 100   k ) ] 2 99 ( 7 ) ɛ ≡ ɛ r  ɛ 0 = 1 2   π · 10 4  Y m ′  ( 10   k ) ] 2 - [ Y m ′  ( 10   k ) ] 2 99 ( 8 ) Blood Conductance [0084] In the 10 and 100 kHz dual-frequency measurement system, the measured magnitude of admittance, |Y(f)|, is blood conductance (g b ) in parallel with myocardial conductance (g m ) and capacitance (C m ), shown as [0000] | Y (10 k )|=√{square root over (( g b +g m ) 2 +(2π·10 4 C m ) 2 )}{square root over (( g b +g m ) 2 +(2π·10 4 C m ) 2 )}  (9) [0000] | Y (100 k )|=√{square root over (( g b +g m ) 2 +(2π·10 5 C m ) 2 )}{square root over (( g b +g m ) 2 +(2π·10 5 C m ) 2 )}  (10) [0000] Using equations (9) and (10), [0000] C m = 1 2   π · 10 4   Y  ( 100   k )  2 -  Y  ( 10   k )  2 99 ( 11 ) g b + g m = 100 ·  Y  ( 10   k )  2 -  Y  ( 100   k )  2 99 ( 12 ) [0000] From the well known conductance-capacitance analogy [40], [0000] g m = C m  σ m ɛ ( 13 ) [0000] Substitute eq. (13) into eq. (12), blood conductance g b is obtained as [0000] g b = ( · 100 ·  Y  ( 10   k )  2 -  Y  ( 100   k )  2 99 ) - g m ( 14 ) [0000] A new conductance-to-volume conversion equation is [0000] Vol ( t )=ρ b L 2 g b ( t )exp[γ·( g b ( t )) 2 ]  (15) [0000] where Vol(t) is the instantaneous volume, ρ b is the blood resistivity, L is the distance between the sensing electrodes, g b (t) is the instantaneous blood conductance, and γ is an empirical calibration factor, which is determined by the following steps. 1. A flow probe is used to measure the LV stroke volume (SV), denoted as SV flow . 2. Assign an initial positive number to γ, and use equation (15) to convert blood conductance to volume signal. The resulting stroke volume is denoted as SVγ. 3. If SVγ is smaller than SV flow , increase the value of γ. Otherwise, decrease it. 4. Repeat steps 2 and 3 until it satisfies. [0000] SVγ−SV flow   (16)  Since equation (15) is a monotonic increasing function, there is only one possible positive solution for γ. [0089] This empirical factor γ is used to compensate and calibrate the overall uncertainty and imperfection of the measurement environment, such as inhomogeneous electrical field and off-center catheter position. Simulation Results [0090] A commercial finite element software, FEMLAB, is used to simulate this problem. A simplified LV model is created by modeling both LV blood and myocardium as cylinders with a four-electrode catheter inserted into the center of cylinders, as shown in FIG. 8 . [0091] The radius of the inner blood cylinder was changed to explore the relationship between volume and conductance. Assuming stroke volume is the difference between the largest and smallest blood volume, and this difference is used to determine the empirical calibration factors, α and γ, for Baan's and the new equations respectively. The calculated magnitude of admittance, blood conductance, true volume, and estimated volume by Baan's and the new equations are listed in Table II and also plotted in FIG. 9 , where the true volume is the volume between the two inner sensing electrodes. The distance between two inner sensing electrodes for a mouse size catheter is 4.5 mm. [0000] TABLE II Comparison of true and estimated volume by two equations Estimated Calculated volume by Estimated magnitude of Blood Baan's volume by admittance conductance True volume equation new equation (μS) (μS) (μL) (μL) (μL) 2491.1 2344.7 62.9 64.5 62.0 2030.2 1853.3 43.7 51.0 43.1 1514.0 1314.3 28.0 36.2 27.5 1337.7 1133.5 23.5 31.2 23.0 1162.4 956.1 19.4 26.3 19.0 992.5 786.4 15.7 21.6 15.3 829.3 626.2 12.4 17.2 12.0 677.3 479.3 9.5 13.2 9.1 538.1 347.9 7.0 9.6 6.6 414.4 234.2 4.9 6.4 4.4 In Vitro Saline Experiments [0092] Several cylinder holes were drilled in a 1.5-inch thick block of Plexiglas. The conductivity of saline used to fill those holes was 1.03 S/m made by dissolving 0.1 M NaCl in 1 liter of water at 23° C. room temperature, which is about the blood conductivity. A conductance catheter with 9 mm distance between electrodes 2 and 3 is used to measure the conductance. [0093] Since plexiglas is an insulating material, the measured conductance comes from saline only, not from the plexiglas wall. Therefore, the measured saline conductance corresponds to the blood conductance in vivo experiments. Again, stroke volume is assumed to be the difference between the largest and smallest blood volume, and then used to determine the empirical calibration factors, α and γ, for Baan's and the new equations, respectively. The measured data at 10 kHz and the estimated volume by Baan's and the new equations are listed in Table III. The true volume listed is the volume between electrodes 2 and 3 . The data are plotted in FIG. 10 . [0000] TABLE III Comparison of true and estimated volume in the drilled holes Estimated volume by Estimated Diameter of Measured Baan's volume by Drilled holes conductance True volume equation new equation (inch) (μS) (μL) (μL) (μL) 3/16 1723.5 160.3 562.0 160.5 ¼ 2675.0 285.0 872.3 310.3 5/16 3376.0 445.3 1100.9 494.5 ⅜ 3836.4 641.3 1251.0 684.8 7/16 4171.0 827.9 1360.1 866.7 ½ 4394.3 1140.1 1432.9 1031.2 [0094] It is found that the resulting volumes obtained from the new equation are much closer to the MRI data, which is believed to be the truth. However, more noise is found in a larger volume by the new method, observed in FIG. 11 . The reason is that as the volume increases, the exponential term of the new equation would amplify the noise more rapidly than the linear Baan's equation. [0095] Although the invention has been described in detail in the foregoing embodiments for the purpose of illustration, it is to be understood that such detail is solely for that purpose and that variations can be made therein by those skilled in the art without departing from the spirit and scope of the invention except as it may be described by the following claims. APPENDIX [0096] The following is a list of references, identified herein, all of which are incorporated by reference herein.

Description

Topics

Download Full PDF Version (Non-Commercial Use)

Patent Citations (9)

    Publication numberPublication dateAssigneeTitle
    US-4854327-AAugust 08, 1989Kunig Horst ENon-invasive and continuous cardiac performance monitoring device
    US-5370122-ADecember 06, 1994Kunig; Horst E., Kunig; Sabine V.Method and apparatus for measuring myocardial impairment, dysfunctions, sufficiency, and insufficiency
    US-5450850-ASeptember 19, 1995Kabushiki Kaisha ToshibaSystem for examining cardiac function
    US-5842998-ADecember 01, 1998Cleveland Clinic Foundation, Marquette Medical SystemsApparatus for determining the conductivity of blood
    US-5882312-AMarch 16, 1999Cleveland Clinic Foundation, Marquette Medical Systems, Inc.Method and apparatus to correct for electric current leakage in conductance volumetry
    US-5925073-AJuly 20, 1999Cardiac Pacemakers, Inc.Intravenous cardiac lead with wave shaped fixation segment
    US-6112115-AAugust 29, 2000Feldman; Marc D., Wu; Clarence, Mahler; ChristineMethod and apparatus for determining cardiac performance in a patient
    US-6494832-B1December 17, 2002Conductance Technologies, Inc.Multifrequency conductance catheter-based system and method to determine LV function in a patient
    US-6545678-B1April 08, 2003Duke UniversityMethods, systems, and computer program products for generating tissue surfaces from volumetric data thereof using boundary traces

NO-Patent Citations (0)

    Title

Cited By (49)

    Publication numberPublication dateAssigneeTitle
    EP-2579780-A4July 05, 2017Angiometrix CorpVerfahren und systeme zur bestimmung von informationen über ein gefässkörperlumen und zur führung medizinischer vorrichtungen
    US-2008190438-A1August 14, 2008Doron Harlev, Adam PidliseckyImpedance registration and catheter tracking
    US-2009253976-A1October 08, 2009Rhythmia Medical, Inc.Intracardiac Tracking System
    US-2010106009-A1April 29, 2010Rhythmia Medical, Inc.Tracking System Using Field Mapping
    US-2010106154-A1April 29, 2010Rhythmia Medical, Inc.Tracking System Using Field Mapping
    US-2010274150-A1October 28, 2010Rhythmia Medical, Inc.Multi-Electrode Mapping System
    US-2010286551-A1November 11, 2010Rhythmia Medical, Inc.Impedance Based Anatomy Generation
    US-2010324414-A1December 23, 2010Rhythmia Medical, Inc., A Delaware CorporationCatheter tracking and endocardium representation generation
    US-2011160574-A1June 30, 2011Rhythmia Medical, Inc.Cardiac mapping with catheter shape information
    US-8137343-B2March 20, 2012Rhythmia Medical, Inc.Tracking system using field mapping
    US-8167876-B2May 01, 2012Rhythmia Medical, Inc.Tracking system using field mapping
    US-8412347-B2April 02, 2013Proteus Digital Health, Inc.Methods and apparatus for leads for implantable devices
    US-8433394-B2April 30, 2013Rhythmia Medical, Inc.Cardiac mapping
    US-8463368-B2June 11, 2013Rhythmia Medical, Inc.Intra-cardiac tracking system
    US-8473069-B2June 25, 2013Proteus Digital Health, Inc.Integrated circuit implementation and fault control system, device, and method
    US-8538509-B2September 17, 2013Rhythmia Medical, Inc.Intracardiac tracking system
    US-8568406-B2October 29, 2013Rhythmia Medical, Inc.Tracking system using field mapping
    US-8571647-B2October 29, 2013Rhythmia Medical, Inc.Impedance based anatomy generation
    US-8615287-B2December 24, 2013Rhythmia Medical, Inc.Catheter tracking and endocardium representation generation
    US-8694074-B2April 08, 2014Rhythmia Medical, Inc.Electrode displacement determination
    US-8700148-B2April 15, 2014Proteus Digital Health, Inc.Methods and apparatus for tissue activation and monitoring
    US-8712549-B2April 29, 2014Proteus Digital Health, Inc.Method and system for monitoring and treating hemodynamic parameters
    US-8725240-B2May 13, 2014Rhythmia Medical, Inc.Intracardiac tracking system
    US-8744566-B2June 03, 2014Rhythmia Medical, Inc.Impedance based anatomy generation
    US-8786049-B2July 22, 2014Proteus Digital Health, Inc.Solid-state thin-film capacitor
    US-8942786-B2January 27, 2015Rhythmia Medical, Inc.Tracking using field mapping
    US-8948853-B2February 03, 2015Rhythmia Medical, Inc.Cardiac mapping with catheter shape information
    US-8989851-B2March 24, 2015Rhythmia Medical, Inc.Cardiac mapping
    US-9002442-B2April 07, 2015Rhythmia Medical, Inc.Beat alignment and selection for cardiac mapping
    US-9014793-B2April 21, 2015Rhythmia Medical, Inc.Intracardiac tracking system
    US-9113809-B2August 25, 2015Rhythmia Medical, Inc.Impedance based anatomy generation
    US-9131869-B2September 15, 2015Rhythmia Medical, Inc.Tracking using field mapping
    US-9277872-B2March 08, 2016Rhythmia Medical, Inc.Electroanatomical mapping
    US-9289148-B2March 22, 2016Rhythmia Medical, Inc.Electroanatomical mapping
    US-9398862-B2July 26, 2016Rhythmia Medical, Inc.Multi-electrode mapping system
    US-9474467-B2October 25, 2016Rhythmia Medical, Inc.Intracardiac tracking system
    US-9498146-B2November 22, 2016Rhythmia Medical, Inc.Electroanatomical mapping
    US-9510769-B2December 06, 2016Rhythmia Medical, Inc.Impedance based anatomy generation
    US-9526434-B2December 27, 2016Rhythmia Medical, Inc.Cardiac mapping with catheter shape information
    US-9585588-B2March 07, 2017Boston Scientific Scimed, Inc.Electrode assembly having an atraumatic distal tip
    US-9636032-B2May 02, 2017Boston Scientific Scimed Inc.Persistent display of nearest beat characteristics during real-time or play-back electrophysiology data visualization
    US-9687166-B2June 27, 2017Boston Scientific Scimed, Inc.High resolution cardiac mapping electrode array catheter
    US-9730602-B2August 15, 2017Boston Scientific Scimed Inc.Cardiac mapping
    US-9808178-B2November 07, 2017Boston Scientific Scimed Inc.Tracking system using field mapping
    US-9848795-B2December 26, 2017Boston Scientific Scimed Inc.Electrode assembly
    WO-2010051183-A1May 06, 2010Rhythmia Medical, Inc.Système de poursuite utilisant le mappage de champ
    WO-2010105250-A2September 16, 2010Proteus Biomedical, Inc.Volume sensing
    WO-2010105250-A3January 13, 2011Proteus Biomedical, Inc.Volume sensing
    WO-2011093991-A1August 04, 2011Board Of Regents, The University Of Texas SystemMethod and apparatus for monitoring an organ of a patient